Across all semaglutide treatment arms, the most frequent AEs were gastrointestinal disorders (most commonly nausea, diarrhoea and vomiting), the majority of which were mild/moderate in severity
Treatment Optimisation If weight loss progress has plateaued or side effects are limiting adherence to your current regimen, switching medicines may help reinvigorate your weight management journey
Customer service was very helpful answering some of my questions
PMID: 3029331 | doi:10.1111/j.1471-4159.1987.tb05655.x Susi V et al
Statistical analyses were performed using GraphPad Prism (version 9.0, GraphPad Software, San Diego, CA, USA)
This guide breaks down the KLOW peptide blend and the GLOW peptide blend side by side: exact ingredient lists, what each compound is thought to contribute in preclinical models, which blend fits which research application, and how the two compare on cost, purity documentation, and handling